background image

Paid Clinical Trials Jackson

Discover 226 paid clinical trials in Jackson, Mississippi. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Linezolid for Syphilis Pilot Study

Recruiting
PHASE2

Sponsor:

University of Southern California

Location:

Jackson MS, Chicago IL

Code:

NCT05548426

Conditions

Syphilis

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

Group B, Linezolid 10d

Group A, Penicillin

A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

Recruiting
PHASE3

Sponsor:

Eli Lilly and Company

Location:

Flowood MS, Ridgeland MS, Pensacola FL, Gulf Breeze FLshow 41 more

Code:

NCT04616326

Conditions

Chronic Migraine

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Galcanezumab

Placebo

A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

Recruiting
PHASE3

Sponsor:

Eli Lilly and Company

Location:

Ridgeland MS, Fayette MS, Baton Rouge LA, Memphis TNshow 172 more

Code:

NCT05026866

Conditions

Alzheimer Disease

Eligibility Criteria

Sex: All

Age: 65 - 70+

Healthy Volunteers: Not accepted

Interventions

Donanemab

Placebo

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Jackson MS, New Orleans LA, Memphis TN, Little Rock ARshow 103 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

Study to Assess the Safety and Efficacy of OCU410ST for Stargardt Disease

Recruiting
PHASE1
PHASE2

Sponsor:

Ocugen

Location:

Jackson MS, Bellaire TX, Dallas TX, Durham NCshow 2 more

Code:

NCT05956626

Conditions

Stargardt Disease

Eligibility Criteria

Sex: All

Age: 6 - 65

Healthy Volunteers: Not accepted

Interventions

OCU410ST

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

Recruiting
PHASE2

Sponsor:

Kowa Research Institute, Inc.

Location:

Flowood MS, Marrero LA, Little Rock AR, Birmingham ALshow 42 more

Code:

NCT05327127

Conditions

NASH

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

K-877-ER

CSG452

Placebo

Do AxoGuard Implants Decrease Shoulder Disability After Neck Dissections

Recruiting

Sponsor:

University of Mississippi Medical Center

Location:

Jackson MS

Code:

NCT03941327

Conditions

Spinal Accessory Nerve Injury

Cervical Lymphadenopathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AxoGuard Nerve Cuff

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Recruiting
PHASE3

Sponsor:

Children's Oncology Group

Location:

Jackson MS, New Orleans LA, Memphis TN, Little Rock ARshow 144 more

Code:

NCT05235165

Conditions

Metastatic Malignant Neoplasm in the Lung

Metastatic Osteosarcoma

Osteosarcoma

Eligibility Criteria

Sex: All

Age: 0 - 50

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Questionnaire Administration

Thoracoscopy

Thoracotomy

Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma

Recruiting
PHASE3

Sponsor:

University of Leicester

Location:

Jackson MS, New Orleans LA, Little Rock AR, Birmingham ALshow 88 more

Code:

NCT00020566

Conditions

Sarcoma

Eligibility Criteria

Sex: All

Age: 0 - 49

Healthy Volunteers: Not accepted

Interventions

dactinomycin

busulfan

doxorubicin hydrochloride

etoposide

ifosfamide

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

Recruiting
PHASE3

Sponsor:

Sanofi

Location:

Ridgeland MS, Covington LA, Lafayette LA, Union City GAshow 46 more

Code:

NCT06130566

Conditions

Dermatitis Atopic

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Amlitelimab

Placebo